Making clinical sense of phenotypes and endotypes of COPD

Daiana Stolz (Switzerland)

Source: ERS Course 2019 - Masterclass in airways disease 2019
Number: 8
Disease area: Airway diseases

Slide presentationWebcast

Rating: 4.5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Daiana Stolz (Switzerland). Making clinical sense of phenotypes and endotypes of COPD. ERS Course 2019 - Masterclass in airways disease 2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Making clinical sense of phenotypes and endotypes of asthma
Source: ERS Course 2019 - Masterclass in airways disease 2019
Year: 2019



COPD phenotypes and endotypes
Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2018


Therapy of COPD based on clinical phenotypes
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017

Distinct clinical phenotypes of airways disease: a primary-care clinician perspective
Source: Eur Respir J 2010; 35: 459
Year: 2010


From phenotypes to endotypes of asthma
Source: International Congress 2014 – PG03 Respiratory medicine: diagnosis to treatment from a mentor and junior perspective
Year: 2014


Asthma endotypes: a new approach to classification of disease entities within asthma
Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping
Year: 2013


Making sense of telemedicine in the management of COPD
Source: Eur Respir J, 51 (5) 1800851; 10.1183/13993003.00851-2018
Year: 2018



Linking phenotypes to personalised treatments in asthma and COPD
Source: Virtual Congress 2021 – Precision medicine in asthma and COPD
Year: 2021


NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice
Source: Eur Respir J, 58 (3) 2100627; 10.1183/13993003.00627-2021
Year: 2021



Cognitive impairment and clinical characteristics in patients with COPD
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016

Clustering asthma and COPD provides new evidence for both “British” and “Dutch” hypotheses of COPD development
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013


Gene expression signatures in airway and nasal epithelium of COPD: linking endotypes to clinical outcomes
Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes
Year: 2017


Defining the clinical clusters of severe asthma within UBIOPRED
Source: International Congress 2015 – Fingerprinting severe asthma
Year: 2015



The distribution of phenotypes in a population of severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014



A proposal of COPD phenotypes
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009

Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021


Distribution of COPD phenotypes according to the Spanish COPD guidelines in clinical practice
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015



COPD: Desadaptive illness behavior types patterns
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015